| PD-L1 | programmed death ligand 1 |
| PD-1 | programmed death 1 |
| VEGF | vascular endothelial growth factor |
| CTLA-4 | cytotoxic T-lymphocyte-associated protein 4 |
| MMR | mismatch repair |
| IL-2 | interleukin 2 |
| TIL | tumor infiltrating lymphocytes |
| BTC | biliary tract cancers |
| HCC | hepatocellular carcinoma |
| CCA | cholangiocarcinoma |
| GBC | gallbladder cancer |
| AFP | alpha fetoprotein |
| GPC-3 | glypican-3 |
| MAGE | melanoma associated antigen |
| NY-ESO-1 | New York esophageal squamous cell carcinoma 1 |
| hTERT | human telomerase reverse transcriptase |
| NKG2DL | natural killer group 2, member D ligand |
| EpCAM | epithelial cellular adhesion molecule |
| CD133 | prominin-1 |
| CD147 | cluster of differentiation 147 |
| MUC1 | mucin 1 |
| EGFR | epidermal growth factor receptor |
| Her2 | human epidermal growth factor receptor |
| SSX-2 | synovial sarcoma X |
| APC | antigen presenting cell |
| NK | natural killer |
| CAR-T | chimeric antigen receptor T cell |